Equities

Research Alliance II Corp

RACB:NAQ

Research Alliance II Corp

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)9.83
  • Today's Change0.015 / 0.15%
  • Shares traded139.58k
  • 1 Year change-0.25%
  • Beta--
Data delayed at least 15 minutes, as of Sep 28 2022 19:20 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Research Alliance Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus on the healthcare industry, with an emphasis on the biotechnology sector. The Company neither engages in any business operations nor generates any revenues.

  • Revenue in USD (TTM)0.00
  • Net income in USD-568.08k
  • Incorporated2020
  • Employees--
  • Location
    Research Alliance II Corp3172 North Rainbow Blvd., #1278LAS VEGAS 89108United StatesUSA
  • Phone+1 (617) 778-2500
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bcls Acquisition Corp0.00-830.79k184.56m----1.29-----0.045-0.0450.007.720.00-------0.574---0.5761--------------0.00-------407.97------
GTEK Industries Inc342.16k-3.39m184.64m5.00------539.62-110.87-110.8713.50-3.430.1909----68,432.00-189.00---326.79--24.54---990.06-----21.321.10-------2,649.34------
Clover Leaf Capital Corp0.00-870.35k185.01m----1.36-----0.0481-0.04810.007.510.00-------1.23---1.24--------------0.00--------------
Credit Suisse High Yield Bond Fund (ETF)20.61m-10.38m185.29m----0.7811--8.99-0.1003-0.10030.19912.290.0585--2.80---2.955.66-4.067.9179.2177.67-50.3683.26----0.3107107.13-14.07-6.37597.415.58---7.66
Pioneer Municpl Hgh Incm Advntg Fund Inc17.42m13.75m185.34m--13.470.6393--10.640.57520.57520.728512.120.0377--3.36--2.98--2.99--70.53--78.95------0.00---7.41--72.84------
Invesco Van Kmpn Trst for Inv Gr NY Mcps-100.00bn-100.00bn185.51m--------------------------------------------------------------
Allspring Global Dividend Opportunty Fnd-100.00bn-100.00bn185.95m--------------------------------------------------------------
Virtus Diversified Income & Convrtble Fd7.27m-907.00k186.64m----0.661--25.67-0.084-0.0840.701827.250.0167--2.39---0.208211.79-0.211812.07-3.9126.94-12.47501.74----0.271174.16-11.58-8.52-100.69----0.1694
Relativity Acquisition Corp-100.00bn-100.00bn187.16m----1.28----------7.87----------------------------0.00--------------
Research Alliance II Corp0.00-568.08k187.84m----1.29-----0.0295-0.02950.007.560.00-------0.3769---0.3772--------------0.00-------5,701.65------
OCA Acquisition Corp0.007.06m188.00m--26.611.30----0.37810.37810.007.710.00------4.63--4.66--------------0.0119------361,329.90------
ARYA Sciences Acquisition Corp V0.00-3.26m188.03m----1.32-----0.1742-0.17420.007.430.00-------4.32---4.41-------------169.300.00--------------
Pioneer High Income Fund Inc27.55m92.41m188.96m--2.040.6727--6.863.163.160.94249.570.0756--38.36--25.376.3825.846.4686.2580.81335.4683.63----0.305394.74-9.30-7.09271.08-----9.03
ARYA Sciences Acquisition Corp IV0.00-6.60m190.33m----1.37-----0.3453-0.34530.007.230.00-------4.39---4.48--------------0.00-------48,362.85------
Pioneer Municipal High Income Fund Inc17.84m10.70m190.37m--17.800.6486--10.670.46980.46980.783318.380.0421--3.11--2.122.962.142.9764.0584.7250.3759.71--5.970.00143.06-4.83-4.58-70.09-26.13---12.00
ABG Acquisition I Corp0.00-769.95k191.20m----1.31-----0.0461-0.04610.007.530.00-------0.5081---0.5089--------------0.00-------2,892.31------
Data as of Sep 28 2022. Currency figures normalised to Research Alliance II Corp's reporting currency: US Dollar USD

Institutional shareholders

62.49%Per cent of shares held by top holders
HolderShares% Held
Saba Capital Management LPas of 30 Jun 20221.91m12.36%
Sculptor Capital LPas of 30 Jun 20221.48m9.57%
Citadel Advisors LLCas of 30 Jun 20221.28m8.28%
Laurion Capital Management LPas of 30 Jun 2022800.00k5.18%
Alyeska Investment Group LPas of 30 Jun 2022800.00k5.18%
Farallon Capital Management LLCas of 30 Jun 2022750.00k4.86%
Shaolin Capital Management LLCas of 30 Jun 2022750.00k4.86%
Woodline Partners LPas of 30 Jun 2022750.00k4.86%
RTW Investments LPas of 30 Jun 2022637.00k4.12%
Suvretta Capital Management LLCas of 30 Jun 2022500.00k3.24%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.